Author: Group of Advisers on the Ethical Implications of Biotechnology of the European Commission
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Opinions of the Group of Advisers on the Ethical Implications of Biotechnology of the European Commission
Author: Group of Advisers on the Ethical Implications of Biotechnology of the European Commission
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Group of Advisers to the European Commission on the Ethical Implications of Biotechnology
Group of Advisers on the Ethical Implications of Biotechnology to the European Commission
Opinions Submitted by the Group of Advisers on the Ethical Implications of Biotechnology to the European Commission
Opinions of the Group of Advisers on the Ethical Implications of Biotechnology of the European Commission 1991-1997
Author: Group of Advisers on the Ethical Implications of Biotechnology of the European Commission
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Group of Advisers to the European Comission on the Ethical Implications of Biotechnology
Author: ComisiĆ³n Europea (Bruselas)
Publisher:
ISBN:
Category :
Languages : en
Pages : 26
Book Description
Recoge: 1.Introduction - 2.Group of advisers on the ethical implications of biotechnology: organization and operation - 3.The work of the group - 4.The general picture.
Publisher:
ISBN:
Category :
Languages : en
Pages : 26
Book Description
Recoge: 1.Introduction - 2.Group of advisers on the ethical implications of biotechnology: organization and operation - 3.The work of the group - 4.The general picture.
The European Group on Ethics in Science and New Technologies (EGE)
Author: European Group on Ethics in Science and New Technologies to the European Commission
Publisher:
ISBN:
Category : Biotechnology
Languages : fr
Pages : 150
Book Description
Publisher:
ISBN:
Category : Biotechnology
Languages : fr
Pages : 150
Book Description
General Report on the Activities of the European Group on Ethics in Science and New Technologies to the European Commission, 2000-2005
Author: European Group on Ethics in Science and New Technologies to the European Commission
Publisher:
ISBN:
Category : Bioethics
Languages : en
Pages : 112
Book Description
Publisher:
ISBN:
Category : Bioethics
Languages : en
Pages : 112
Book Description
Modern Biotechnology in Postmodern Times?
Author: L. Reuter
Publisher: Springer Science & Business Media
ISBN: 9400710151
Category : Philosophy
Languages : en
Pages : 263
Book Description
This book is for bioethicists, ethicists (theologians/philosophers), professionals in biotechnology, EU and national policymakers, and professors/teachers of courses in applied ethics. It presents an interdisciplinary reflection on the nature and scope of current biotechnology in Europe. It offers a concise presentation of the current biotechnological arena in Europe with its ethical implications and provides a survey of topical Council of Europe documents and treaties.
Publisher: Springer Science & Business Media
ISBN: 9400710151
Category : Philosophy
Languages : en
Pages : 263
Book Description
This book is for bioethicists, ethicists (theologians/philosophers), professionals in biotechnology, EU and national policymakers, and professors/teachers of courses in applied ethics. It presents an interdisciplinary reflection on the nature and scope of current biotechnology in Europe. It offers a concise presentation of the current biotechnological arena in Europe with its ethical implications and provides a survey of topical Council of Europe documents and treaties.
Bioproperty, Biomedicine and Deliberative Governance
Author: Katerina Sideri
Publisher: Routledge
ISBN: 1317174194
Category : Law
Languages : en
Pages : 205
Book Description
Biomedical patents have been the subject of heated debate. Regulatory agencies such as the European Patent Office make small decisions with big implications, which escape scrutiny and revision, when they decide who has access to expensive diagnostic tests, whether human embryonic stem cells can be traded in markets, and under what circumstances human health is more important than animal welfare. Moreover, the administration of the Trade Related Aspects of Intellectual Property Rights by the World Trade Organization has raised considerable disquiet as it has arguably created grave health inequities. Those doubting the merits of the one size fits all approach ask whether priority should be given to serving the present needs of populations in dire need of medication or to promoting global innovation. The book looks in detail into the legal issues and ethical debates to ask the following three main questions: First, what are the ideas, goals, and broader ethical visions that underpin questions of governance and the legal reasoning employed by administrative agencies? Second, how can we democratize the decision making process of technocratic institutions such as the European Patent Office? Finally, how can we make the global intellectual property system more equitable? In answering these questions the book seeks to contribute to our understanding of the role and function of regulatory agencies in the regulation of the bioeconomy, explains the process of interpretation of legal norms, and proposes ways to rethink the reform of the patent system through the lens of legitimacy.
Publisher: Routledge
ISBN: 1317174194
Category : Law
Languages : en
Pages : 205
Book Description
Biomedical patents have been the subject of heated debate. Regulatory agencies such as the European Patent Office make small decisions with big implications, which escape scrutiny and revision, when they decide who has access to expensive diagnostic tests, whether human embryonic stem cells can be traded in markets, and under what circumstances human health is more important than animal welfare. Moreover, the administration of the Trade Related Aspects of Intellectual Property Rights by the World Trade Organization has raised considerable disquiet as it has arguably created grave health inequities. Those doubting the merits of the one size fits all approach ask whether priority should be given to serving the present needs of populations in dire need of medication or to promoting global innovation. The book looks in detail into the legal issues and ethical debates to ask the following three main questions: First, what are the ideas, goals, and broader ethical visions that underpin questions of governance and the legal reasoning employed by administrative agencies? Second, how can we democratize the decision making process of technocratic institutions such as the European Patent Office? Finally, how can we make the global intellectual property system more equitable? In answering these questions the book seeks to contribute to our understanding of the role and function of regulatory agencies in the regulation of the bioeconomy, explains the process of interpretation of legal norms, and proposes ways to rethink the reform of the patent system through the lens of legitimacy.